Red and orange laser operation of Pr:KYF4 pumped by a Nd:YAG/LBO laser at 469.1nm and a InGaN laser diode at 444nm

We report the basic luminescence properties and the continuous-wave (CW) laser operation of a Pr3+-doped KYF4 single crystal in the Red and Orange spectral regions by using a new pumping scheme. The pump source is an especially developed, compact, slightly tunable and intra-cavity frequency-doubled diode-pumped Nd:YAG laser delivering a CW output power up to about 1.4 W around 469.1 nm. At this pump wavelength, red and orange laser emissions are obtained at about 642.3 and 605.5 nm, with maximum output powers of 11.3 and 1 mW and associated slope efficiencies of 9.3% and 3.4%, with respect to absorbed pump powers, respectively. For comparison, the Pr:KYF4 crystal is also pumped by a InGaN blue laser diode operating around 444 nm. In this case, the same red and orange lasers are obtained, but with maximum output powers of 7.8 and 2 mW and the associated slope efficiencies of 7 and 5.8%, respectively. Wavelength tuning for the two lasers is demonstrated by slightly tilting the crystal. Orange laser operation and laser wavelength tuning are reported for the first time

A modeling approach to assess the hydrological response of small mediterranean catchments to the variability of soil characteristics in a context of extreme events

This paper presents a modeling study aiming at quantifying the possible impact of soil characteristics on the hydrological response of small ungauged catchments in a context of extreme events. The study focuses on the September 2002 event in the Gard region (South-Eastern France), which led to catastrophic flash-floods. The proposed modeling approach is able to take into account rainfall variability and soil profiles variability. Its spatial discretization is determined using Digital Elevation Model (DEM) and a soil map. The model computes infiltration, ponding and vertical soil water distribution, as well as river discharge. In order to be applicable to ungauged catchments, the model is set up without any calibration and the soil parameter specification is based on an existing soil database. The model verification is based on a regional evaluation using 17 estimated discharges obtained from an extensive post-flood investigation. Thus, this approach provides a spatial view of the hydrological response across a large range of scales. To perform the simulations, radar rainfall estimations are used at a 1 km<sup>2</sup> and 5 min resolution. To specify the soil hydraulic properties, two types of pedotransfer function (PTF) are compared. It is shown that the PTF including information about soil structure reflects better the spatial variability that can be encountered in the field. The study is focused on four small ungauged catchments of less than 10 km<sup>2</sup>, which experienced casualties. Simulated specific peak discharges are found to be in agreement with estimations from a post-event in situ investigation. Examining the dynamics of simulated infiltration and saturation degrees, two different behaviors are shown which correspond to different runoff production mechanisms that could be encountered within catchments of less than 10 km<sup>2</sup>. They produce simulated runoff coefficients that evolve in time and highlight the variability of the infiltration capacity of the various soil types. Therefore, we propose a cartography distinguishing between areas prone to saturation excess and areas prone only to infiltration excess mechanisms. The questions raised by this modeling study will be useful to improve field observations, aiming at better understanding runoff generation for these extreme events and examine the possibility for early warning, even in very small ungauged catchments

Prevalence of deep and ovarian endometriosis in women attending a general gynecology clinic: prospective cohort study

Objectives: To assess using transvaginal ultrasound the prevalence of deep and ovarian endometriosis in premenopausal women attending a general gynecology clinic. We also investigated whether the presence of endometriosis was associated with various demographic factors and other pelvic abnormalities. Methods: This was a prospective observational cohort study carried out between February 2019 and October 2020. Consecutive premenopausal women who attended our general gynecology clinic underwent pelvic ultrasound examination, performed by a single experienced operator. Pregnant women and those with a history of hysterectomy or oophorectomy were excluded. The primary outcome was the prevalence of deep and/or ovarian endometriosis. Secondary outcomes were the anatomical distribution of endometriotic lesions and the association of endometriosis with demographic characteristics and various pelvic abnormalities, which were analyzed using logistic regression and multivariable analysis. Results: A total of 1026 women were included in the final study sample, of whom 194 (18.9% (95% CI, 16.6–21.4%)) had sonographic evidence of deep and/or ovarian endometriosis. Of the 194 women diagnosed with endometriosis, 106 (54.6% (95% CI, 47.4–61.8%)) were diagnosed with endometriotic nodules only, 26 (13.4% (95% CI, 9.0–19.0%)) with ovarian endometriomas only, and 62 (32.0% (95% CI, 25.5–39.0%)) women had evidence of both. There was a total of 348 endometriotic nodules in 168 women, located most frequently in the retrocervical area (166/348; 47.7% (95% CI, 42.4–53.1%)), uterosacral ligaments (96/348; 27.6% (95% CI, 23.0–32.6%)) and bowel (40/348; 11.5% (95% CI, 8.3–15.3%)). Multivariable analysis found significant positive associations between endometriosis and both adenomyosis (odds ratio (OR), 1.72 (95% CI, 1.10–2.69); P = 0.02) and pelvic adhesions (OR, 25.7 (95% CI, 16.7–39.3); P < 0.001), whilst higher parity (OR, 0.44 (95% CI, 0.24–0.81); P = 0.03) and history of Cesarean section (OR, 0.18 (95% CI, 0.06–0.52); P = 0.002) were associated with a lower occurrence of endometriosis. A total of 75/1026 women (7.3% (95% CI, 5.8–9.1%)) underwent laparoscopy within 6 months of pelvic ultrasound examination. There was very good agreement between ultrasound and surgical findings, with a kappa value of 0.84 (95% CI, 0.69–0.99). Conclusions: Deep and/or ovarian endometriosis was present in nearly one in five women attending a general gynecology clinic. There were significant positive associations with adenomyosis and pelvic adhesions and negative associations with higher parity and previous Cesarean section

Turbulent separated shear flow control by surface plasma actuator: experimental optimization by genetic algorithm approach

The potential benefits of active flow control are no more debated. Among many others applications, flow control provides an effective mean for manipulating turbulent separated flows. Here, a nonthermal surface plasma discharge (dielectric barrier discharge) is installed at the step corner of a backward-facing step (U&nbsp;0&nbsp;=&nbsp;15&nbsp;m/s,&nbsp;Re&nbsp;h&nbsp;&nbsp;=&nbsp;30,000,&nbsp;Re&nbsp;&theta;&nbsp;&nbsp;=&nbsp;1650). Wall pressure sensors are used to estimate the reattaching location downstream of the step (objective function #1) and also to measure the wall pressure fluctuation coefficients (objective function #2). An autonomous multi-variable optimization by genetic algorithm is implemented in an experiment for optimizing simultaneously the voltage amplitude, the burst frequency and the duty cycle of the high-voltage signal producing the surface plasma discharge. The single-objective optimization problems concern alternatively the minimization of the objective function #1 and the maximization of the objective function #2. The present paper demonstrates that when coupled with the plasma actuator and the wall pressure sensors, the genetic algorithm can find the optimum forcing conditions in only a few generations. At the end of the iterative search process, the minimum reattaching position is achieved by forcing the flow at the shear layer mode where a large spreading rate is obtained by increasing the periodicity of the vortex street and by enhancing the vortex pairing process. The objective function #2 is maximized for an actuation at half the shear layer mode. In this specific forcing mode, time-resolved PIV shows that the vortex pairing is reduced and that the strong fluctuations of the wall pressure coefficients result from the periodic passages of flow structures whose size corresponds to the height of the step model

Investigating the impact of two decades of urbanization on the water balance of the Yzeron peri-urban catchment, France

International audienceThis paper addresses the impact of 18 years of urbanization (1990-2008) on the Yzeron meso-scale peri-urban catchment (150 km²), located close to Lyon, France. A simplified version of the distributed hydrological model J2000 was used to perform long term simulations at a daily time step for several land use scenarios. These scenarios were derived from satellite SPOT images from years 1990, 1999 and 2008. The corresponding land use maps were classified into 5 classes depending on the percentage of impervious surfaces and the dominant non-impervious land use (agriculture or forest). The paper presents the methodology for the model setup and the simulation results for the main water balance components of the catchment: total runoff, runoff components, evapotranspiration and soil moisture. The results highlight the change of the catchment seasonal response from 1990 to 2008, mainly due to a change of the respective contributions of groundwater flow / surface runoff (+ 92% / - 28%, respectively). Monthly mean summer discharge unexpectedly appears to be higher in summer. It is provided by intermittent surface runoff generated by summer storm events. As surface runoff generated on urban surfaces is likely to carry a wide range of contaminants, this has a potential large impact on water quality

Performance improvement of the multicell cavity prototype for proton Linac projects

The CEA-Saclay / IPN-Orsay collaboration allowed to manufacture a multicell superconducting RF cavity prototype for proton linac. Since the first experimental results [1], obtained in a vertical cryostat and the horizontal cryostat CryHoLab, the accelerating field Eacc has been recently increased up to 19 MV/m with a quality factor Q0 = 9.109 and a limitation by quench. However some improvements are still needed, in particular to suppress the field emission above 16 MV/m

A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors

Background: Volasertib is a potent and selective cell-cycle kinase inhibitor that induces mitotic arrest and apoptosis by targeting Polo-like kinases. This study determined the maximum tolerated dose (MTD) and pharmacokinetics of volasertib combined with nintedanib, a potent and orally bioavailable triple angiokinase inhibitor, in patients with advanced solid tumors. Patients and methods: This open-label, dose-escalation trial recruited patients with advanced metastatic solid tumors following failure of conventional treatment (NCT01022853; Study 1230.7). Volasertib was administered by intravenous infusion over 2 h, starting at 100 mg in the first dose cohort. Nintedanib was administered orally at a dose of 200 mg twice daily. The first treatment cycle comprised 28 days (days 1-7 and days 9-28: nintedanib; day 8: volasertib). From cycle 2 onwards, volasertib was administered on day 1 of a 21-day cycle and nintedanib was administered days 2-21. The primary objective was the MTD of volasertib in combination with nintedanib. Results: Thirty patients were treated. The MTD of volasertib plus fixed-dose nintedanib was 300 mg once every 3 weeks, the same as the recommended single-agent dose of volasertib in solid tumors. Two of 12 assessable patients treated with the MTD experienced dose-limiting toxicities [grade 3 increased alanine aminotransferase (ALT); grade 3 ALT increase and grade 3 increased aspartate aminotransferase]. Disease control [stable disease (SD)/partial response (PR)/complete response (CR)] was achieved in 18 patients (60%): 1 CR (breast cancer), 1 PR (nonsmall-cell lung cancer), and 16 patients with SD. Volasertib showed that multiexponential pharmacokinetic behavior and co-administration of nintedanib had no significant effects on its exposure. Conclusions: Volasertib could be combined with fixed-dose nintedanib at the recommended single-agent dose. At this dose, the combination had a manageable safety profile without unexpected or overlapping adverse events, and showed antitumor activity

Prognostic value of clinicopathological parameters in head and neck squamous cell carcinoma: a prospective analysis.

The prognostic weight of histological and biological factors was compared with that of known clinical prognostic factors in a population of 108 consecutive previously untreated patients with head and neck squamous cell carcinoma. Parameters studied were: tumour vascularisation, mitotic index, histological differentiation, nuclear grade, keratinisation, desmoplasia, growth pattern, inflammation, tumour emboli in peripheral vessels, keratins 6, 13, 19 immunohistochemical expression, cytofluorometric ploidy and S-phase. In multivariate analysis (Cox), only age and nodal status had a significant impact on the overall survival, whereas T stage was the only significant factor associated with locoregional failure. The cumulative incidence of metastases was correlated not only with age, T and N stage, but also with histological differentiation. All the other histological and biological factors studied failed to provide further prognostic information. These findings may help to select patients with high metastatic risk

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study

Background Eribulin mesylate (E) is indicated for metastatic breast cancer patients previously treated with anthracycline and taxane. We argued that E could also benefit patients eligible for neoadjuvant chemotherapy. Methods Patients with primary triple negative breast cancer 2 cm received doxorubicin 60 mg/m2 and paclitaxel 200 mg/m2 x 4 cycles (AT) followed by E 1.4 mg/m2 x 4 cycles. Primary endpoint was pathological complete response (pCR) rate; secondary and explorative endpoints included clinical/metabolic response rates and safety, and biomarker analysis, respectively. Using a two-stage Simon design, 43 patients were to be included provided that 4 of 13 patients had achieved pCR in the first stage of the study. Results In stage I of the study 13 women were enrolled, median age 43 years, tumor size 2–5 cm in 9/13 (69%), positive nodal status in 8/13 (61%). Main grade 3 adverse event was neutropenia (related to AT and E in 4 and 2 cases, respectively). AT followed by E induced clinical complete + partial responses in 11/13 patients (85%), pCR in 3/13 (23%). Median measurements of maximum standardized uptake value (SUVmax) resulted 13, 3, and 1.9 at baseline, after AT and E, respectively. Complete metabolic response (CMR) occurred after AT and after E in 2 and 3 cases, respectively. Notably, 2 of the 5 (40%) patients with CMR achieved pCR at surgery. Immunostaining of paired pre-/post-treatment tumor specimens showed a reduction of β-catenin, CyclinD1, Zeb-1, and c-myc expression, in the absence of N-cadherin modulation. The study was interrupted at stage I due to the lack of the required patients with pCR. Conclusions Despite the early study closure, preoperative E following AT showed clinical and biological activity in triple negative breast cancer patients. Furthermore, the modulation of β-catenin pathway core proteins, supposedly outside the domain of epithelial–mesenchymal transition, claims for further investigation. Trial registration EU Clinical Trial Register, EudraCT number 2012-004956-12